Speech-Language Pathologists in Birdsboro, PA Accepting Medicare

2 Speech-Language Pathologists found. Showing 1 - 2

Kristin Swartley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 41 Troxel Rd, Birdsboro, PA 19508 Phone: 616-689-8417

Rachel Gerhart Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 251 Old Tulpehocken Rd, Birdsboro, PA 19508 Phone: 610-404-0049

News Archive

RL Solutions, 3M to offer new software for minimizing risk of healthcare-acquired infections

3M Infection Prevention and RL Solutions today announced a joint feasibility program to provide healthcare facilities data on the rate of infection in real-time and the costs associated with those infections.

Researchers use personalized simulations of the brain to uncover nature of internal processes

The brain is an adaptable and highly complex system. However, much remains to be known about the way in which individual components of the brain interact in order to produce cognitive performance.

Artificial CSP proteins reduce S. pneumoniae competence y more than 90%

The bacterium Streptococcus pneumoniae - which can cause pneumonia, meningitis, bacteremia and sepsis - likes to share its antibiotic-defeating weaponry with its neighbors. Individual cells can pass resistance genes to one another through a process called horizontal gene transfer, or by "transformation," the uptake of DNA from the environment.

A model of vaccine-derived herd immunity against COVID-19 in heterogeneous populations

A recent theoretical paper, currently available on the medRxiv preprint server, unveils a novel vaccination model that shows how a herd immunity threshold (HIT) value which considers heterogeneity is substantially lower in comparison with a HIT value of assuming a homogeneous population – with many implications for further vaccination planning.

Lipocine files new patent applications in support of oral testosterone product for hypogonadism

Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.

Read more Medical News

› Verified 7 days ago